April Global Macro Monthly - Macron encore
- 27 April 2022 (7 min read)
Key points
- The Ukraine war continues. Energy markets have been relatively cushioned, but commodity prices are elevated and supply-chain disruption has risen. This is an issue for European economies, but is impacting economies across the globe, with Asian central banks increasingly tightening
- The worsening inflation outlook has seen central bank expectations re-price higher. In the US, markets now see rates at 2.75% by year-end and 3.25% next. We expect a marked growth deceleration to moderate expectations, but regional labour market developments will be critical.
- China’s Covid outbreak adds to risks. China growth slowed markedly in March – before the Shanghai lockdown. We expect a fall in Q2 GDP and lower our full-year growth forecast. This suggests demand headwinds for the rest of the world, but also risks further supply disruption.
- This is a toxic combination of factors and has led the International Monetary Fund to lower its global forecasts to 3.6% for 2022 and 2023. Our own outlook is for a weaker 3.0% and 2.9%.
Disclaimer
This document is for informational purposes only and does not constitute investment research or financial analysis relating to transactions in financial instruments as per MIF Directive (2014/65/EU), nor does it constitute on the part of AXA Investment Managers or its affiliated companies an offer to buy or sell any investments, products or services, and should not be considered as solicitation or investment, legal or tax advice, a recommendation for an investment strategy or a personalized recommendation to buy or sell securities.
It has been established on the basis of data, projections, forecasts, anticipations and hypothesis which are subjective. Its analysis and conclusions are the expression of an opinion, based on available data at a specific date.
All information in this document is established on data made public by official providers of economic and market statistics. AXA Investment Managers disclaims any and all liability relating to a decision based on or for reliance on this document. All exhibits included in this document, unless stated otherwise, are as of the publication date of this document.
Furthermore, due to the subjective nature of these opinions and analysis, these data, projections, forecasts, anticipations, hypothesis, etc. are not necessary used or followed by AXA IM’s portfolio management teams or its affiliates, who may act based on their own opinions. Any reproduction of this information, in whole or in part is, unless otherwise authorised by AXA IM, prohibited.